TMPO and posterior cortical atrophy: In agreement with these results, Huang et al. demonstrated that in PCa, TMPO-AS1 acted an oncogenic lncRNA, and might represent a diagnostic and prognostic biomarker and a therapeutic target, for PCa [23].